Filing Details
- Accession Number:
- 0002001011-24-000088
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-24 19:41:37
- Reporting Period:
- 2024-09-20
- Accepted Time:
- 2024-09-24 19:41:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
886163 | Ligand Pharmaceuticals Inc | LGND | Pharmaceutical Preparations (2834) | 770160744 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1905248 | Octavio Espinoza | 555 Heritage Drive Suite 200 Jupiter FL 33458 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-09-20 | 200 | $103.98 | 25,685 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-09-20 | 275 | $103.86 | 25,410 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-09-20 | 800 | $103.95 | 24,610 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |